NCT03809364
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Human Sciences Research Council Pietermaritzburg, KwaZulu-Natal, South Africa
Clinical trial condition
Slow Virus Diseases
Explore clinical trials studying Slow Virus Diseases. Study availability and eligibility vary by location and protocol.
2,616 public trials
184 recruiting studies
Slow Virus Diseases trial results
NCT02872805
- Conditions
- AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +15 more
- Locations
-
- Institute of Human Virology, Nigeria Abuja, Federal Capital Territory, Nigeria
NCT04070287
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +17 more
- Locations
-
- Nigerian Institute of Medical Research Yaba, Lagos, Nigeria
NCT05270135
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Bloodstream Infection, +28 more
- Locations
-
- University of Arizona College of Medicine Tucson, Arizona, United States
Completed
Clinic-based ART Diagnostic Evaluation
NCT01791556
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Kenya Medical Research Institute/ Walter Reed Project HIV Program Kericho, Kenya
NCT05776108
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
- Locations
-
- GSK Investigational Site Austin, Texas, United States
NCT00643903
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
NCT02831764
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Sacramento, California, United States
- GSK Investigational Site San Francisco, California, United States
Completed
Relative Bioavailability Study to Investigate a Potential Interaction Between DTG DT and F/TAF TOS.
NCT05489406
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- RTCCS Radboudumc Nijmegen, Netherlands
NCT03826199
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Gugulethu Midwife Obstetric Unit Cape Town, South Africa